Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-wzw2p Total loading time: 0 Render date: 2024-05-08T07:08:07.168Z Has data issue: false hasContentIssue false

Chapter 12 - Tumors of the female genital system

Published online by Cambridge University Press:  05 November 2015

John M. S. Bartlett
Affiliation:
Ontario Institute for Cancer Research, Toronto
Abeer Shaaban
Affiliation:
Queen Elizabeth Hospital Birmingham
Fernando Schmitt
Affiliation:
University of Porto
Get access
Type
Chapter
Information
Molecular Pathology
A Practical Guide for the Surgical Pathologist and Cytopathologist
, pp. 174 - 188
Publisher: Cambridge University Press
Print publication year: 2015

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Munoz, N., Bosch, F. X., de Sanjose, S., Herrero, R., Castellsague, X., Shah, K.V. et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. New Engl J Med 2003; 348(6): 518–27.CrossRefGoogle ScholarPubMed
Schiffman, M. H., Bauer, H. M., Hoover, R. N., Glass, A. G., Cadell, D. M., Rush, B. B. et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993; 85(12): 958–64.CrossRefGoogle ScholarPubMed
zur Hausen, H. and de Villiers, E. M. Human papillomaviruses. Annu Rev Microbiol 1994; 48: 427–47.CrossRefGoogle ScholarPubMed
Klingelhutz, A. J. and Roman, A. Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses. Virology 2012; 424(2): 7798.CrossRefGoogle ScholarPubMed
Wentzensen, N., Vinokurova, S. and von Knebel Doeberitz, M. Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res 2004; 64(11): 3878–84.CrossRefGoogle ScholarPubMed
Wise-Draper, T. M. and Wells, S. I. Papillomavirus E6 and E7 proteins and their cellular targets. Front Biosci 2008; 13: 1003–17.CrossRefGoogle ScholarPubMed
Munger, K. and Phelps, W. C. The human papillomavirus E7 protein as a transforming and transactivating factor. Biochim Biophys Acta 1993; 1155(1): 111–23.Google ScholarPubMed
Liu, X., Clements, A., Zhao, K. and Marmorstein, R. Structure of the human Papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor. J Biol Chem 2006; 281(1): 578–86.Google ScholarPubMed
Sano, T., Oyama, T., Kashiwabara, K., Fukuda, T. and Nakajima, T. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 1998; 153(6): 1741–8.CrossRefGoogle ScholarPubMed
Sano, T., Oyama, T., Kashiwabara, K., Fukuda, T. and Nakajima, T. Immunohistochemical overexpression of p16 protein associated with intact retinoblastoma protein expression in cervical cancer and cervical intraepithelial neoplasia. Pathol Int 1998; 48(8): 580–5.CrossRefGoogle ScholarPubMed
Agoff, S. N., Lin, P., Morihara, J., Mao, C., Kiviat, N. B. and Koutsky, L. A. p16(INK4a) expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types. Mod Pathol 2003; 16(7): 665–73.CrossRefGoogle ScholarPubMed
Darragh, T. M., Colgan, T. J., Cox, J. T., Heller, D. S., Henry, M. R. and Luff, R. D. et al. The lower anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. J Low Genit Tract Dis 2012; 16(3): 205–42.CrossRefGoogle ScholarPubMed
Longatto-Filho, A. and Schmitt, F. C. Cytology education in the 21st century: living in the past or crossing the Rubicon? Acta Cytol 2010; 54(4): 654–6.Google Scholar
Arbyn, M., Anttila, A., Jordan, J., Ronco, G., Schenck, U., Segnan, N. et al. (eds.), European Guidelines for Quality Assurance in Cervical Cancer Screening, 2nd edn (City of Luxembourg, Grand Duchy of Luxembourg: Office for Official Publications of the European Communities, 2008).Google Scholar
Saslow, D., Solomon, D., Herschel, W., Killackey, M., Kulasingam, S., Cain, J., Garcia, F. A. R. et al. ACS-ASCCP-ASCP Cervical Cancer Guideline Committee. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin 2012; 62(3): 147–72.CrossRefGoogle ScholarPubMed
Brown, C. A., Bogers, J., Sahebali, S., Depuydt, C. E., De Prins, F. and Malinowski, D. P. et al. Role of protein biomarkers in the detection of high-grade disease in cervical cancer screening programs. J Oncol 2012; 2012:289315.CrossRefGoogle ScholarPubMed
Carcangiu, M. L., Herrington, S., Kurman, R. J. and Young, R. H. (eds.), Tumours of the Female Genital Organs (Lyon: IARC Press, 2014).Google Scholar
Conklin, C. M. and Longacre, T. A. Endometrial stromal tumors: the new WHO classification. Adv Anat Pathol 2014; 21(6): 383–93.CrossRefGoogle ScholarPubMed
Kloppel, G., Couvelard, A., Perren, A., Komminoth, P., McNicol, A. M., Nilsson, O. et al. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. Neuroendocrinology 2009; 90(2): 162–6.CrossRefGoogle Scholar
Lax, S. F. Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification. Virchows Arch 2004; 444(3): 213–23.CrossRefGoogle ScholarPubMed
Sherman, M. E., Bur, M. E. and Kurman, R. J. p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis. Hum Pathol 1995; 26(11): 1268–74.CrossRefGoogle ScholarPubMed
Lax, S. F., Pizer, E. S., Ronnett, B. M. and Kurman, R. J. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression. Hum Pathol 1998; 29(6): 551–8.CrossRefGoogle ScholarPubMed
Lax, S. F. Molecular genetic changes in epithelial, stromal and mixed neoplasms of the endometrium. Pathology 2007; 39(1): 4654.CrossRefGoogle ScholarPubMed
Kurman, R. J., Ellenson, L. H. and Ronnett, B. M. (eds.), Blaustein's Pathology of the Female Genital Tract, 6th edn. (New York: Springer Verlag, 2011).CrossRefGoogle Scholar
Bozic, I., Antal, T., Ohtsuki, H., Carter, H., Kim, D., Chen, S. et al. Accumulation of driver and passenger mutations during tumor progression. Proc Natl Acad Sci USA 2010; 107(43): 18545–50.CrossRefGoogle ScholarPubMed
Humphries, A., Cereser, B., Gay, L. J., Miller, D. S., Das, B., Gutteridge, A. et al. Lineage tracing reveals multipotent stem cells maintain human adenomas and the pattern of clonal expansion in tumor evolution. Proc Natl Acad Sci USA 2013; 110(27): E2490–9.CrossRefGoogle ScholarPubMed
Baker, S. J. PTEN enters the nuclear age. Cell 2007; 128(1): 25–8.CrossRefGoogle ScholarPubMed
Chow, L. M. and Baker, S. J. PTEN function in normal and neoplastic growth. Cancer Lett 2006; 241(2): 184–96.CrossRefGoogle ScholarPubMed
Mutter, G. L. Pten, a protean tumor suppressor. Am J Pathol 2001; 158(6): 1895–8.CrossRefGoogle ScholarPubMed
Tashiro, H., Blazes, M. S., Wu, R., Cho, K. R., Bose, S., Wang, S. I. et al. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res 1997; 57(18): 3935–40.Google ScholarPubMed
Bussaglia, E., del Rio, E., Matias-Guiu, X. and Prat, J. PTEN mutations in endometrial carcinomas: a molecular and clinicopathologic analysis of 38 cases. Hum Pathol 2000; 31(3): 312–17.CrossRefGoogle ScholarPubMed
Diaz-Padilla, I., Romero, N., Amir, E., Matias-Guiu, X., Vilar, E., Muggia, F. et al. Mismatch repair status and clinical outcome in endometrial cancer: a systematic review and meta-analysis. Crit Rev Oncol Hematol 2013; 88(1): 154–67.CrossRefGoogle ScholarPubMed
Baak, J. P., Van Diermen, B., Steinbakk, A., Janssen, E., Skaland, I., Mutter, G. L. et al. Lack of PTEN expression in endometrial intraepithelial neoplasia is correlated with cancer progression. Hum Pathol 2005; 36(5): 555–61.CrossRefGoogle ScholarPubMed
Mutter, G. L., Lin, M. C., Fitzgerald, J. T., Kum, J. B., Baak, J. P., Lees, J. A. et al. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J Natl Cancer Inst 2000; 92(11): 924–30.CrossRefGoogle ScholarPubMed
Monte, N. M., Webster, K. A., Neuberg, D., Dressler, G. R. and Mutter, G. L. Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer. Cancer Res 2010; 70(15): 6225–32.CrossRefGoogle ScholarPubMed
Scholten, A. N., Creutzberg, C. L., van den Broek, L. J., Noordijk, E. M. and Smit, V. T. Nuclear beta-catenin is a molecular feature of type I endometrial carcinoma. J Pathol 2003; 201(3): 460–5.CrossRefGoogle ScholarPubMed
Machin, P., Catasus, L., Pons, C., Munoz, J., Matias-Guiu, X. and Prat, J. CTNNB1 mutations and beta-catenin expression in endometrial carcinomas. Hum Pathol 2002; 33(2): 206–12.CrossRefGoogle ScholarPubMed
Gatius, S., Velasco, A., Azueta, A., Santacana, M., Pallares, J., Valls, J. et al. FGFR2 alterations in endometrial carcinoma. Modern Pathol 2011; 24(11): 1500–10.CrossRefGoogle ScholarPubMed
Lax, S. F., Kendall, B., Tashiro, H., Slebos, R. J. and Hedrick, L. The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways. Cancer 2000; 88(4): 814–24.3.0.CO;2-U>CrossRefGoogle ScholarPubMed
Esteller, M., Catasus, L., Matias-Guiu, X., Mutter, G. L., Prat, J., Baylin, S. B. et al. hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis. Am J Pathol 1999; 155(5): 1767–72.CrossRefGoogle ScholarPubMed
Tashiro, H., Isacson, C., Levine, R., Kurman, R. J., Cho, K. R. and Hedrick, L. p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis. Am J Pathol 1997; 150(1): 177–85.Google ScholarPubMed
Hayes, M. P. and Ellenson, L. H. Molecular alterations in uterine serous carcinoma. Gynecol Oncol 2010; 116(2): 286–9.CrossRefGoogle ScholarPubMed
Morrison, C., Zanagnolo, V., Ramirez, N., Cohn, D. E., Kelbick, N., Copeland, L. et al. HER-2 is an independent prognostic factor in endometrial cancer: association with outcome in a large cohort of surgically staged patients. J Clin Oncol 2006; 24(15): 2376–85.CrossRefGoogle Scholar
Tashiro, H., Lax, S. F., Gaudin, P. B., Isacson, C., Cho, K. R. and Hedrick, L. Microsatellite instability is uncommon in uterine serous carcinoma. Am J Pathol 1997; 150(1): 75–9.Google ScholarPubMed
Kuhn, E., Bahadirli-Talbott, A. and Shih, I. M. Frequent CCNE1 amplification in endometrial intraepithelial carcinoma and uterine serous carcinoma. Mod Pathol 2013; 27(7): 1014–19.Google ScholarPubMed
An, H. J., Logani, S., Isacson, C. and Ellenson, L. H. Molecular characterization of uterine clear cell carcinoma. Mod Pathol 2004; 17(5): 530–7.CrossRefGoogle ScholarPubMed
Guan, B., Mao, T. L., Panuganti, P. K., Kuhn, E., Kurman, R. J., Maeda, D. et al. Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma. Am J Surg Pathol 2011; 35(5): 625–32.CrossRefGoogle ScholarPubMed
Wiegand, K. C., Lee, A. F., Al-Agha, O. M., Chow, C., Kalloger, S. E., Scott, D. W. et al. Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas. J Pathol 2011; 224(3): 328–33.CrossRefGoogle ScholarPubMed
Cancer Genome Atlas Research Network, Kandoth, C., Schultz, N., Cherniack, A. D., Akbani, R., Liu, Y. et al. Integrated genomic characterization of endometrial carcinoma. Nature 2013; 497(7447): 6773.Google ScholarPubMed
Ferlay, J., Shin, H. R., Bray, F., Forman, D., Mathers, C. and Parkin, D. M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127(12): 2893–917.CrossRefGoogle ScholarPubMed
Prat, J. Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features. Virchows Arch 2012; 460(3): 237–49.CrossRefGoogle ScholarPubMed
Rechsteiner, M., Zimmermann, A. K., Wild, P. J., Caduff, R., von Teichman, A., Fink, D. et al. TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type. Exp Mol Pathol 2013; 95(2): 235–41.CrossRefGoogle ScholarPubMed
Perets, R., Wyant, G. A., Muto, K. W., Bijron, J. G., Poole, B. B., Chin, K. T. et al. Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models. Cancer Cell 2013; 24(6): 751–65.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×